Thiopeptide Antibacterial Agents Targeting EF-Tu
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rapid emergence of bacterial resistance, particularly to vancomycin, among Gram-positive pathogens like Staphylococcus aureus and increasing incidence of methicillin-resistant Staphylococcus aureus (MRSA), necessitates new molecular entities effective against multidrug-resistant bacteria.
Innovation Solution
Development of thiopeptide compounds that modulate the activity of elongation factor EF-Tu, interfering with the bacterial life cycle and treating bacterial infections by inhibiting or preventing EF-Tu activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing antibiotics are used to treat bacterial infections, then bacterial infections can be treated effectively, but bacterial resistance to these antibiotics emerges and increases
Solution Approach 1:
The patent employs parameter changes by modifying the chemical structure of thiopeptide compounds through various substitutions and modifications (as shown in the general formula and specific embodiments) to create new molecular entities with improved antibacterial activity against resistant strains while maintaining or reducing resistance development
Solution Approach 2:
The patent utilizes composite materials by combining thiopeptide core structures with various substituent groups (aromatic rings, heterocyclic groups, side chains) to create complex hybrid molecular structures that exhibit enhanced activity against multidrug-resistant bacteria including MRSA and vancomycin-resistant strains
2Reliability
If new molecular entities are developed to combat multidrug-resistant bacteria, then effectiveness against resistant strains improves, but development complexity and time increase
Solution Approach 1:
The patent applies segmentation by dividing the thiopeptide molecular structure into distinct functional modules (core thiopeptide ring, substituent groups at positions 2, 4, 5, side chains) that can be independently modified and optimized to achieve desired antibacterial activity while managing structural complexity
Solution Approach 2:
The patent implements universality by designing a general thiopeptide scaffold (Formula I) that serves as a universal platform for developing multiple specific compounds with activity against various multidrug-resistant bacteria, allowing one core structure to fulfill multiple therapeutic functions
Data Source
AI summary
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.